Cardiovascular outcomes in the AFFIRM trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management): An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses

Journal of the American College of Cardiology

Volumn 58, Issue 19, 2011, Pages 1975-1985

  Saksena, Sanjeev ^a   Slee, April ^a   Waldo, Albert L ^a   Freemantle, Nick ^a   Reynolds, Mathew ^a   Rosenberg, Yves ^b   Rathod, Snehal ^a   Grant, Shannon ^a   Thomas, Elizabeth ^a   Wyse, D George ^a  

^a Electrophysiology Research Foundation   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

antiarrhythmic drugs; atrial fibrillation; cardiovascular hospitalizations; cardiovascular outcomes; clinical trials; outcomes research

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLECAINIDE; PROPAFENONE; SOTALOL;

AGED; ANGINA PECTORIS; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART RATE; HEART RHYTHM; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CLINICAL TRIALS AS TOPIC; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED;

EID: 80055022990     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.07.036     Document Type: Article

References (22)

1. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: The Framingham Heart Study Circulation 98 1998 946 952 (Pubitemid 28446646)
2. AF Hospitalizations in the USA, June 2009 http://www.nhlbi.nih.gov/ resources/docs/2009-ChartBook.pdf chart 3-47 & 3-48. Accessed September 13, 2011
3. Y. Miyasaka, M.E. Barnes, and B.J. Gersh Changing trends of hospital utilization in patients after their first episode of atrial fibrillation Am J Cardiol 102 2008 568 572
4. The Planning and Steering Committees of the AFFIRM Study for the NHLBI AFFIRM Investigators Atrial fibrillation follow-up investigation of rhythm managementthe AFFIRM study design Am J Cardiol 79 1997 1198 1202
5. The AFFIRM Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
6. S.D. Corley, A.E. Epstein, J.P. DiMarco AFFIRM Investigators Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study Circulation 109 2004 1509 1513 (Pubitemid 38420179)
7. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 1983 41 55
8. N. Freemantle, M. Calvert, J. Wood, J. Eastaugh, and C. Griffin Composite outcomes in randomized trialsgreater precision with greater uncertainty JAMA 289 2003 2554 2559 (Pubitemid 37430157)
9. AFFIRM First Antiarrhythmic Drug Substudy Investigators Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM sub study of the first antiarrhythmic drug J Am Coll Cardiol 42 2003 20 29
10. H. Akaike A new look at the statistical model identification IEEE Trans on Automatic Control 19 1974 716 723
11. D.G. Sherman, S.G. Kim, B.S. Boop National Heart, Lung, and Blood Institute AFFIRM Investigators Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study Arch Intern Med 165 2005 1185 1191 (Pubitemid 40723655)
12. D.G. Wyse, A. Slee, and A.E. Epstein Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experience Heart Rhythm 1 2004 531 537 (Pubitemid 39462710)
13. L.S. Jenkins, M. Brodsky, and E. Schron Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Am Heart J 149 2005 112 120
14. J.S. Steinberg, A. Sadaniantz, and J. Kron Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Circulation 109 2004 1973 1980 (Pubitemid 38552376)
15. S.H. Hohnloser, H.J. Crijns, M. van Eickels ATHENA Investigators Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678
16. D.J. Wilber, C. Pappone, P. Neuzil ThermoCool AF Trial Investigators Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial JAMA 303 2010 333 340
17. J.L. Bosco, R.A. Silliman, and S.S. Thwin A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies J Clin Epidemiol 63 2010 64 74
18. O.M. Wazni, N.F. Marrouche, and D.O. Martin Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial JAMA 293 2005 2634 2640 (Pubitemid 40744248)
19. G. Stabile, E. Bertaglia, and G. Senatore Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study) Eur Heart J 27 2006 216 221 (Pubitemid 43069040)
20. B.H. Rao, and S. Saksena Impact of "hybrid therapy" on long-term rhythm control and arrhythmia related hospitalizations in patients with drug-refractory persistent and permanent atrial fibrillation J Interv Card Electrophysiol 18 2007 127 136 (Pubitemid 46835771)
21. G. Naccarelli, S. Johnston, J. Lin, P. Patel, and K. Schulman Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States clinical cardiology 33 2010 270 279
22. F. Khairallah, R. Ezzedine, L.I. Ganz, B. London, and S. Saba Epidemiology and determinants of outcome of admissions for atrial fibrillation in the United States from 1996 to 2001 Am J Cardiol 94 2004 500 504 (Pubitemid 39120005)